Home/Filings/4/0001104659-25-015319
4//SEC Filing

German Christopher Paul 4

Accession 0001104659-25-015319

CIK 0001649904other

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 9:45 PM ET

Size

20.0 KB

Accession

0001104659-25-015319

Insider Transaction Report

Form 4
Period: 2025-02-14
German Christopher Paul
Corporate Controller & CAO
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-16+1,8072,705 total
  • Sale

    Common Stock

    2025-02-19$57.22/sh635$36,3352,070 total
  • Award

    Restricted Stock Units

    2025-02-14+7,2257,225 total
    Common Stock (7,225 underlying)
  • Award

    Stock Options (Right to Buy)

    2025-02-14+5,4005,400 total
    Exercise: $56.69Exp: 2035-02-13Common Stock (5,400 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2025-02-161,8075,418 total
    Common Stock (1,807 underlying)
Footnotes (6)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
  • [F2]Includes 103 additional shares acquired under the Issuer's Employee Stock Purchase Plan.
  • [F3]The sale reported in this Form 4 was effected pursuant to non-Rule 10b5-1 trading arrangement, as defined in Item 408(a) of Regulation S-K, solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.
  • [F4]The restricted stock units vest as to 25% of the total shares on each of February 14, 2026, February 14, 2027, February 14, 2028 and February 14, 2029. The restricted stock units have no expiration date.
  • [F5]The stock options were granted on February 14, 2025. The options vest and become exercisable in 16 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer following the grant date.
  • [F6]The restricted stock units vest as to 25% of the total shares on each of February 16, 2025, February 16, 2026, February 16, 2027 and February 16, 2028. The restricted stock units have no expiration date.

Issuer

RHYTHM PHARMACEUTICALS, INC.

CIK 0001649904

Entity typeother

Related Parties

1
  • filerCIK 0001260835

Filing Metadata

Form type
4
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 9:45 PM ET
Size
20.0 KB